Literature DB >> 7890533

Advances in understanding and novel therapeutic targets in inflammatory arthritis.

O FitzGerald1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7890533     DOI： 10.1007/bf02968105

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  9 in total

1.  Activation-independent binding of human memory T cells to adhesion molecule ELAM-1.

Authors:  Y Shimizu; S Shaw; N Graber; T V Gopal; K J Horgan; G A Van Seventer; W Newman
Journal:  Nature       Date:  1991-02-28       Impact factor: 49.962

2.  Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis.

Authors:  O FitzGerald; M Soden; G Yanni; R Robinson; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1.

Authors:  M M Corkill; B W Kirkham; D O Haskard; C Barbatis; T Gibson; G S Panayi
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

4.  Quantitative studies of human monokine-induced endothelial cell elongation.

Authors:  O M FitzGerald; E V Hess; A Chance; R F Highsmith
Journal:  J Leukoc Biol       Date:  1987-05       Impact factor: 4.962

5.  Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation.

Authors:  T Iguchi; M Ziff
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 6.  Leucocyte-endothelial interactions and regulation of leucocyte migration.

Authors:  D H Adams; S Shaw
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

7.  Alterations in human endothelial cell morphology, proliferation and function by a macrophage-derived factor.

Authors:  M Heffernan; A Chance; E V Hess; R F Highsmith; O FitzGerald
Journal:  Ir J Med Sci       Date:  1994-08       Impact factor: 1.568

8.  Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis.

Authors:  D Veale; G Yanni; S Rogers; L Barnes; B Bresnihan; O Fitzgerald
Journal:  Arthritis Rheum       Date:  1993-07

9.  Classification of clinical subsets in psoriatic arthritis.

Authors:  D Veale; S Rogers; O Fitzgerald
Journal:  Br J Rheumatol       Date:  1994-02
  9 in total
  3 in total

Review 1.  Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.

Authors:  P J Mease
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

Review 2.  Altered bone remodeling in psoriatic arthritis.

Authors:  Kofi A Mensah; Edward M Schwarz; Christopher T Ritchlin
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

3.  Boi-ogi-to (TJ-20), a Kampo Formula, Suppresses the Inflammatory Bone Destruction and the Expression of Cytokines in the Synovia of Ankle Joints of Adjuvant Arthritic Rats.

Authors:  Xinwen Zhang; Zhou Wu; Yicong Liu; Junjun Ni; Chunfu Deng; Baohong Zhao; Hiroshi Nakanishi; Jing He; Xu Yan
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-07       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.